LivaNova (NASDAQ:LIVN) Sees Unusually-High Trading Volume

LivaNova PLC (NASDAQ:LIVN) saw unusually-strong trading volume on Thursday . Approximately 1,827,857 shares traded hands during trading, an increase of 183% from the previous session’s volume of 646,774 shares.The stock last traded at $51.38 and had previously closed at $49.99.

Analyst Ratings Changes

A number of research analysts have weighed in on the stock. Robert W. Baird boosted their target price on shares of LivaNova from $58.00 to $66.00 and gave the company a “neutral” rating in a research note on Thursday, May 2nd. Needham & Company LLC reissued a “buy” rating and set a $72.00 price objective on shares of LivaNova in a report on Thursday, June 6th. StockNews.com upgraded LivaNova from a “hold” rating to a “buy” rating in a research note on Thursday, April 25th. Finally, Mizuho increased their price target on LivaNova from $75.00 to $80.00 and gave the stock a “buy” rating in a research note on Thursday, May 2nd. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $66.20.

LivaNova Stock Up 4.9 %

The stock has a market capitalization of $2.84 billion, a P/E ratio of -83.32 and a beta of 0.99. The company has a debt-to-equity ratio of 0.50, a current ratio of 3.17 and a quick ratio of 2.71. The stock has a fifty day moving average price of $57.27 and a 200 day moving average price of $54.26.

LivaNova (NASDAQ:LIVN) last posted its earnings results on Wednesday, May 1st. The company reported $0.73 earnings per share for the quarter, beating analysts’ consensus estimates of $0.45 by $0.28. LivaNova had a positive return on equity of 13.59% and a negative net margin of 2.68%. The business had revenue of $294.90 million during the quarter, compared to analyst estimates of $278.17 million. During the same quarter in the previous year, the firm earned $0.43 EPS. The company’s quarterly revenue was up 12.0% compared to the same quarter last year. On average, research analysts forecast that LivaNova PLC will post 2.6 earnings per share for the current year.

Insiders Place Their Bets

In related news, Director Daniel Jeffrey Moore sold 56,623 shares of LivaNova stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $60.11, for a total transaction of $3,403,608.53. Following the completion of the sale, the director now owns 27,534 shares of the company’s stock, valued at $1,655,068.74. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.27% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. New York State Teachers Retirement System raised its stake in shares of LivaNova by 0.3% during the first quarter. New York State Teachers Retirement System now owns 64,322 shares of the company’s stock worth $3,598,000 after acquiring an additional 200 shares in the last quarter. State of Michigan Retirement System boosted its position in LivaNova by 2.3% during the first quarter. State of Michigan Retirement System now owns 13,211 shares of the company’s stock valued at $739,000 after buying an additional 300 shares during the period. Louisiana State Employees Retirement System grew its stake in shares of LivaNova by 2.6% during the first quarter. Louisiana State Employees Retirement System now owns 15,500 shares of the company’s stock valued at $867,000 after buying an additional 400 shares during the last quarter. Headlands Technologies LLC increased its holdings in shares of LivaNova by 33.3% in the fourth quarter. Headlands Technologies LLC now owns 1,807 shares of the company’s stock worth $93,000 after buying an additional 451 shares during the period. Finally, ProShare Advisors LLC lifted its stake in shares of LivaNova by 4.7% in the 1st quarter. ProShare Advisors LLC now owns 12,378 shares of the company’s stock valued at $692,000 after acquiring an additional 561 shares during the last quarter. Institutional investors own 97.64% of the company’s stock.

About LivaNova

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.